Coal India Stake Sale Government Sets OFS Floor Price at Rs 412 Discounted from Market Barclays Reports 18 Profit Increase and Lifts FullYear Income Forecast Food and Beverage Industry Shifts Manufacturing Investment Strategies Singapore Stocks Edge Higher Amid Cautious MidEast Sentiment STI Gains 04 UiPath and Deloitte Expand Collaboration with Test Cloud Integration into Ascend Platform BuzzBallz 99p Shot Faces Criticism from Alcohol Charities Over Youth Appeal GTE Q4 2025 Earnings Net Loss Reported Amid Energy Sector Volatility Prudential Financial Q1 2026 Earnings Strong EPS Beat Signals Resilient Core Operations SJM Q1 2026 Earnings EPS Beats Estimates by 36 Amid Strong Operational Execution PRU Q1 2026 Earnings Earnings Beat Estimates by 154 Amid Solid Insurance Performance STTK Q1 2026 Earnings Narrowerthanexpected loss highlights cost discipline amid prerevenue stage ZVIA Q1 2026 Earnings NarrowerThanExpected Loss Drives DoubleDigit Stock Gain Montauk Renewables MNTK Gains 42 as Renewable Energy Stock Finds Support Near 153 Newegg Commerce NEGG Slips 44 as Resistance Holds Above 1950 California BanCorp BCAL Holds Steady with Modest Gain as Stock Nears Resistance Aurelion Inc AURE Slips Nearly 2 as Stock Nears Key Support GIII Apparel Group GIII Rises 28 as Stock Approaches Key Resistance Level China Urges APEC Cooperation Amid Commerce Ministers Absence Trade Representative Steps In Sensient Technologies SXT Q1 2026 Earnings Strong EPS Surprise Drives Stock Gain Rithm Capital RITM Holds Steady at 926 as Markets Eye Key Support and Resistance Levels MLAB Q1 2026 Earnings Earnings Per Share Surges Past Estimates by Over 130 DUK Q1 2026 Earnings Utility Giant Beats Estimates as Regulatory Gains Offset Cost Pressures HHS Q2 2025 Earnings Narrower Loss and Modest Stock Gain Amid Sparse Disclosures Supernus Pharmaceuticals SUPN Q1 2026 Earnings EPS Surges Past Expectations but Stock Retreats Iovance Biotherapeutics Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Operational Momentum BCS Q1 2026 Earnings EPS Beat by 1036 Despite Slight Stock Decline CLGN Q4 2025 Earnings EPS Misses Estimates as Biotech Continues PreRevenue Phase